W.A. van Deijk

417 total citations
13 papers, 326 citations indexed

About

W.A. van Deijk is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, W.A. van Deijk has authored 13 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in W.A. van Deijk's work include Hemophilia Treatment and Research (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). W.A. van Deijk is often cited by papers focused on Hemophilia Treatment and Research (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). W.A. van Deijk collaborates with scholars based in Netherlands and United States. W.A. van Deijk's co-authors include Hanneke C. Kluin‐Nelemans, M.C.E. van Dam-Mieras, Jos Hermans, E.M. Noordijk, M Krámer, Ed Schuuring, Carla J. de Boer, P. M. Kluin, Gerjo A. Velders and H.C. Hemker and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

W.A. van Deijk

13 papers receiving 320 citations

Peers

W.A. van Deijk

ONCOL

PFM

HEMAT

PRM

GENET

B. Steinke Germany

S F Williams United States

S Schryber United States

Wei‐Shu Wang Taiwan

Marc Jones United Kingdom

Jules H. Blank United States

Michelle Purdom United States

A Congiu Italy

Benjamin M. Parsons United States

Anne Marie Boesen Denmark

B. Steinke Germany

W.A. van Deijk

137 ×0.8

ONCOL

52 ×0.3

PFM

86 ×1.0

HEMAT

46 ×0.6

PRM

36 ×0.6

GENET

Citations per year, relative to W.A. van Deijk W.A. van Deijk (= 1×) peers B. Steinke

Countries citing papers authored by W.A. van Deijk

Since Specialization

Citations

This map shows the geographic impact of W.A. van Deijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.A. van Deijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.A. van Deijk more than expected).

Fields of papers citing papers by W.A. van Deijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.A. van Deijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.A. van Deijk. The network helps show where W.A. van Deijk may publish in the future.

Co-authorship network of co-authors of W.A. van Deijk

This figure shows the co-authorship network connecting the top 25 collaborators of W.A. van Deijk. A scholar is included among the top collaborators of W.A. van Deijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.A. van Deijk. W.A. van Deijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Schaar, C. G., Hanneke C. Kluin‐Nelemans, Saskia le Cessie, et al.. (2005). Interferon-α as maintenance therapy in patients with multiple myeloma. Annals of Oncology. 16(4). 634–639. 41 indexed citations

Velders, Gerjo A., Hanneke C. Kluin‐Nelemans, Carla J. de Boer, et al.. (1996). Mantle-cell lymphoma. Journal of Clinical Oncology. 14(4). 3 indexed citations

Velders, Gerjo A., Hanneke C. Kluin‐Nelemans, Carla J. de Boer, et al.. (1996). Mantle-cell lymphoma: a population-based clinical study.. Journal of Clinical Oncology. 14(4). 1269–1274. 143 indexed citations

Geelkerken, R.H., et al.. (1994). Sweet syndrome associated with liposarcoma: a case report.. PubMed. 45(3). 107–9. 2 indexed citations

Schornagel, Jan H., S. van der Vegt, Jaap Verweij, et al.. (1992). Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer. Annals of Oncology. 3(7). 549–552. 29 indexed citations

Schornagel, Jan H., Jaap Verweij, W.W. ten Bokkel Huinink, et al.. (1989). Phase II Study of Recombinant Interferon Alpha-2A and Vinblastine in Advanced Renal Cell Carcinoma. The Journal of Urology. 142(2 Part 1). 253–256. 18 indexed citations

Blijham, G.H., et al.. (1986). Angina pectoris associated with infusions of 5-FU and vindesine.. PubMed. 70(2). 314–5. 11 indexed citations

Müller, Axel, et al.. (1986). The activity state of factor VII in plasma: two pathways for the cold promoted activation of factor VII. British Journal of Haematology. 62(2). 367–377. 10 indexed citations

Dam-Mieras, M.C.E. van, et al.. (1985). Clotting factors secreted by monocytes and macrophages: Analytical considerations. Thrombosis Research. 37(1). 9–19. 21 indexed citations

10.

Deijk, W.A. van, G.H. Blijham, W. A. M. Mellink, & P. M. M. Meulenberg. (1985). Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.. PubMed. 69(1). 85–90. 14 indexed citations

11.

Deijk, W.A. van, et al.. (1983). Activation of Factor VII in Patients with Carcinoma of the Prostate. Pathophysiology of Haemostasis and Thrombosis. 13(3). 198–200. 12 indexed citations

12.

Deijk, W.A. van, M.C.E. van Dam-Mieras, Axel Müller, & H.C. Hemker. (1983). Evaluation of a Coagulation Assay Determining the Activity State of Factor VII in Plasma. Pathophysiology of Haemostasis and Thrombosis. 13(3). 192–197. 20 indexed citations

13.

Deijk, W.A. van, et al.. (1979). Primary adrenal insufficiency with hypertension. A case report on partial primary adrenal insufficiency and partial 11-beta-hydroxylase deficiency.. PubMed. 22(6). 191–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact